These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 19705573)

  • 1. Reduction of the cerebrovascular volume in a transgenic mouse model of Alzheimer's disease.
    Bourasset F; Ouellet M; Tremblay C; Julien C; Do TM; Oddo S; LaFerla F; Calon F
    Neuropharmacology; 2009 Mar; 56(4):808-13. PubMed ID: 19705573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered cerebral vascular volumes and solute transport at the blood-brain barriers of two transgenic mouse models of Alzheimer's disease.
    Do TM; Alata W; Dodacki A; Traversy MT; Chacun H; Pradier L; Scherrmann JM; Farinotti R; Calon F; Bourasset F
    Neuropharmacology; 2014 Jun; 81():311-7. PubMed ID: 24631967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).
    Do TM; Dodacki A; Alata W; Calon F; Nicolic S; Scherrmann JM; Farinotti R; Bourasset F
    J Alzheimers Dis; 2016; 49(2):287-300. PubMed ID: 26484906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modifications of physical and functional integrity of the blood-brain barrier in an inducible mouse model of neurodegeneration.
    Taccola C; Barneoud P; Cartot-Cotton S; Valente D; Schussler N; Saubaméa B; Chasseigneaux S; Cochois V; Mignon V; Curis E; Lochus M; Nicolic S; Dodacki A; Cisternino S; Declèves X; Bourasset F
    Neuropharmacology; 2021 Jun; 191():108588. PubMed ID: 33940010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic overproduction of transforming growth factor-beta1 by astrocytes promotes Alzheimer's disease-like microvascular degeneration in transgenic mice.
    Wyss-Coray T; Lin C; Sanan DA; Mucke L; Masliah E
    Am J Pathol; 2000 Jan; 156(1):139-50. PubMed ID: 10623661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tau pathology-dependent remodelling of cerebral arteries precedes Alzheimer's disease-related microvascular cerebral amyloid angiopathy.
    Merlini M; Wanner D; Nitsch RM
    Acta Neuropathol; 2016 May; 131(5):737-52. PubMed ID: 26988843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tau induces blood vessel abnormalities and angiogenesis-related gene expression in P301L transgenic mice and human Alzheimer's disease.
    Bennett RE; Robbins AB; Hu M; Cao X; Betensky RA; Clark T; Das S; Hyman BT
    Proc Natl Acad Sci U S A; 2018 Feb; 115(6):E1289-E1298. PubMed ID: 29358399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model.
    Hirata-Fukae C; Li HF; Hoe HS; Gray AJ; Minami SS; Hamada K; Niikura T; Hua F; Tsukagoshi-Nagai H; Horikoshi-Sakuraba Y; Mughal M; Rebeck GW; LaFerla FM; Mattson MP; Iwata N; Saido TC; Klein WL; Duff KE; Aisen PS; Matsuoka Y
    Brain Res; 2008 Jun; 1216():92-103. PubMed ID: 18486110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depressive-like behavior is paired to monoaminergic alteration in a murine model of Alzheimer's disease.
    Romano A; Pace L; Tempesta B; Lavecchia AM; Macheda T; Bedse G; Petrella A; Cifani C; Serviddio G; Vendemiale G; Gaetani S; Cassano T
    Int J Neuropsychopharmacol; 2014 Oct; 18(4):. PubMed ID: 25609597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice.
    Aliev G; Seyidova D; Lamb BT; Obrenovich ME; Siedlak SL; Vinters HV; Friedland RP; LaManna JC; Smith MA; Perry G
    Neurol Res; 2003 Sep; 25(6):665-74. PubMed ID: 14503022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrovascular pathology during the progression of experimental Alzheimer's disease.
    Giannoni P; Arango-Lievano M; Neves ID; Rousset MC; Baranger K; Rivera S; Jeanneteau F; Claeysen S; Marchi N
    Neurobiol Dis; 2016 Apr; 88():107-17. PubMed ID: 26774030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease-like cerebrovascular pathology in transforming growth factor-beta 1 transgenic mice and functional metabolic correlates.
    Wyss-Coray T; Lin C; von Euw D; Masliah E; Mucke L; Lacombe P
    Ann N Y Acad Sci; 2000 Apr; 903():317-23. PubMed ID: 10818521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A; Xu X; Bi X; Baudry M
    J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficiency in mural vascular cells coincides with blood-brain barrier disruption in Alzheimer's disease.
    Sengillo JD; Winkler EA; Walker CT; Sullivan JS; Johnson M; Zlokovic BV
    Brain Pathol; 2013 May; 23(3):303-10. PubMed ID: 23126372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stroke-induced opposite and age-dependent changes of vessel-associated markers in co-morbid transgenic mice with Alzheimer-like alterations.
    Hawkes CA; Michalski D; Anders R; Nissel S; Grosche J; Bechmann I; Carare RO; Härtig W
    Exp Neurol; 2013 Dec; 250():270-81. PubMed ID: 24103194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a 3xTg-AD mouse model of Alzheimer's disease with the senescence accelerated mouse prone 8 (SAMP8) background.
    Virgili J; Lebbadi M; Tremblay C; St-Amour I; Pierrisnard C; Faucher-Genest A; Emond V; Julien C; Calon F
    Synapse; 2018 Apr; 72(4):. PubMed ID: 29341269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered brain uptake of therapeutics in a triple transgenic mouse model of Alzheimer's disease.
    Mehta DC; Short JL; Nicolazzo JA
    Pharm Res; 2013 Nov; 30(11):2868-79. PubMed ID: 23794039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toluidine blue O modifies hippocampal amyloid pathology in a transgenic mouse model of Alzheimer's disease.
    Yuksel M; Biberoglu K; Onder S; Akbulut KG; Tacal O
    Biochimie; 2018 Mar; 146():105-112. PubMed ID: 29248542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tau passive immunization inhibits not only tau but also Aβ pathology.
    Dai CL; Tung YC; Liu F; Gong CX; Iqbal K
    Alzheimers Res Ther; 2017 Jan; 9(1):1. PubMed ID: 28073379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of Hydrogen Sulfide against the Progression of Severe Alzheimer's Disease in Transgenic Mice at Different Ages.
    Vandini E; Ottani A; Zaffe D; Calevro A; Canalini F; Cavallini GM; Rossi R; Guarini S; Giuliani D
    Pharmacology; 2019; 103(1-2):50-60. PubMed ID: 30448835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.